By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.
-
-
HYOSCYAMINE SULFATE (Generic for NULEV)
- QTY 60
- 0.125 MG
- TAB RAPDIS
- Near 77381
HYOSCYAMINE (hye oh SYE a meen) treats the symptoms of many conditions, such as irritable bowel syndrome (IBS), stomach ulcers, and bladder spasms. It works by relaxing the muscles in your digestive tract and bladder. It also reduces the amount of sweat, saliva, and stomach acid your body makes. It belongs to a group of medications called antispasmodics.
Change Location
Set Price Drop Alert for:
HYOSCYAMINE SULFATE (Generic for NULEV)
- QTY 60
- 0.125 MG
- TAB RAPDIS
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
HYOSCYAMINE SULFATE (Generic for NULEV)
- QTY 60
- 0.125 MG
- TAB RAPDIS
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
HYOSCYAMINE SULFATE (Generic for NULEV) Lifestyle Interactions
-
Ubrogepant 100mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during ubrogepant treatment due to the risk for increased ubrogepant exposure and adverse reactions. Ubrogepant is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
